Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib Phase 1/2 in Japanese Patients
NCT01684215Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2012
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in solid tumor, breast cancer, sponsored by Pfizer. Started Oct 2012; status: completed.
02
Drugs
palbociclib
03
Conditions
solid tumorbreast cancer
Beyond the preview
Go deeper on NCT01684215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01684215.